Capital Restructuring

KALA BIO Implements 1-for-50 Reverse Stock Split, Reducing Outstanding Shares from 929.5 Million to 18.6 Million

KALA BIO Implements 1-for-50 Reverse Stock Split, Reducing Outstanding Shares from 929.5 Million to 18.6 Million

KALA BIO executed a 1-for-50 reverse stock split to meet Nasdaq listing requirements and consolidate its capital structure, effective May 11, 2026.

May 8, 2026
Catalyst Crew Technologies CEO to Cancel 50% of Common Stock Holdings in Equity Restructuring

Catalyst Crew Technologies CEO to Cancel 50% of Common Stock Holdings in Equity Restructuring

Catalyst Crew Technologies CEO Kevin Roldan Levy will cancel up to half of his restricted common shares in exchange for preferred equity, aiming to optimize the capital structure and align leadership with long-term strategic goals.

April 30, 2026
tZERO TZROP Holders Approve Conversion, Paving Way for Capital Restructuring

tZERO TZROP Holders Approve Conversion, Paving Way for Capital Restructuring

tZERO Group's TZROP token holders approved a conversion into common and preferred stock, simplifying the capital structure and enabling a potential $10 million investment from Bed Bath & Beyond.

April 29, 2026